Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
11.1M
-
Shares change
-
-577K
-
Total reported value, excl. options
-
$79.8M
-
Value change
-
-$4.87M
-
Number of buys
-
24
-
Number of sells
-
-14
-
Price
-
$7.17
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q4 2016
59 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q4 2016.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.1M shares
of 86.6M outstanding shares and own 12.85% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (2.34M shares), MPM ASSET MANAGEMENT LLC (2.17M shares), FMR LLC (1.48M shares), BlackRock Advisors LLC (1.03M shares), ORBIMED ADVISORS LLC (757K shares), VANGUARD GROUP INC (390K shares), EcoR1 Capital, LLC (274K shares), Arrowpoint Asset Management, LLC (266K shares), Cormorant Asset Management, LLC (240K shares), and Boxer Capital, LLC (234K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.